Literature DB >> 34537928

Progesterone and estrogen levels are associated with live birth rates following artificial cycle frozen embryo transfers.

Ronit Beck-Fruchter1,2, Simon Nothman3,4, Shira Baram3, Yoel Geslevich3, Amir Weiss3,4.   

Abstract

PURPOSE: Does an association exist between serum progesterone and estradiol levels and live birth rates in artificial cycle frozen embryo transfer (AC-FET)?
METHODS: Retrospective cohort study was based on prospectively collected data at a university-affiliated fertility center. Included were all cycles using an artificial endometrial preparation with estradiol hemihydrate (Estrofem, 2 mg/8 h) and vaginal progesterone (Endometrin 100 mg/8 h), autologous oocytes, and cleavage stage embryo transfers. Serum progesterone and estradiol levels were measured 14 days after FET. A total of 921 cycles in 568 patients from to December 2010 to June 2019 were investigated. Live birth was the primary outcome measure.
RESULTS: Significant association was found between live birth and progesterone as well as estradiol levels (progesterone 14.65 vs 11.62 ng/ml, p = 0.001; estradiol 355.12 vs 287.67 pg/ml, p = 0.001). A significant difference in live birth rate was found below and above the median progesterone level (10.9 ng/ml, p = 0.007). Lower estradiol level was significantly associated with lower live birth rate (< 188.2 pg/ml 8.3%, > 263.1 pg/ml 16%, p = 0.02).
CONCLUSIONS: Serum progesterone and estradiol levels impact live birth rate in AC-FET.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Artificial cycle frozen embryo transfer (AC-FET); Estrogen/estradiol; Frozen embryo transfer (FET); Live birth rate; Progesterone

Mesh:

Substances:

Year:  2021        PMID: 34537928      PMCID: PMC8608954          DOI: 10.1007/s10815-021-02307-w

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  38 in total

Review 1.  Pharmacokinetics of the progesterone-containing vaginal tablet and its use in assisted reproduction.

Authors:  T Levy; Y Yairi; I Bar-Hava; J Shalev; R Orvieto; Z Ben-Rafael
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

2.  Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet.

Authors:  T Levy; S Gurevitch; I Bar-Hava; J Ashkenazi; A Magazanik; R Homburg; R Orvieto; Z Ben-Rafael
Journal:  Hum Reprod       Date:  1999-03       Impact factor: 6.918

3.  Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement.

Authors:  Silvina Bocca; Elvira Bondía Real; Susanna Lynch; Laurel Stadtmauer; Hind Beydoun; Jacob Mayer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2015-01-07       Impact factor: 3.412

4.  Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert.

Authors:  Richard J Paulson; Michael G Collins; Vladimir I Yankov
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

Review 5.  Progesterone and the luteal phase: a requisite to reproduction.

Authors:  Tolga B Mesen; Steven L Young
Journal:  Obstet Gynecol Clin North Am       Date:  2015-01-05       Impact factor: 2.844

6.  Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates.

Authors:  Rani Fritz; Sangita Jindal; Heather Feil; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2017-08-19       Impact factor: 3.412

7.  Serum progesterone levels on day of embryo transfer in frozen embryo transfer cycles-the truth lies in the detail.

Authors:  Birgit Alsbjerg; Elena Labarta; Peter Humaidan
Journal:  J Assist Reprod Genet       Date:  2020-06-12       Impact factor: 3.412

Review 8.  Progesterone use in assisted reproductive technology.

Authors:  Elena Labarta; Cristina Rodríguez
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-04       Impact factor: 5.237

9.  Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone.

Authors:  D F Archer; G E Fahy; A Viniegra-Sibal; F D Anderson; W Snipes; R G Foldesy
Journal:  Am J Obstet Gynecol       Date:  1995-08       Impact factor: 8.661

10.  Non-inferiority of cleavage-stage versus blastocyst-stage embryo transfer in poor prognosis IVF patients (PRECiSE trial): study protocol for a randomized controlled trial.

Authors:  Werner M Neuhausser; Denis A Vaughan; Denny Sakkas; Michele R Hacker; Tom Toth; Alan Penzias
Journal:  Reprod Health       Date:  2020-01-30       Impact factor: 3.223

View more
  2 in total

1.  Comparison of natural and artificial cycles in frozen-thawed embryo transfer: A retrospective analysis of 1696 cycles.

Authors:  Erhan Demirdağ; İsmail Güler; Münire Funda Cevher Akdulum; Esin Şahin; Ayşe Duygu Tufan; Ahmet Erdem; Mehmet Erdem
Journal:  Turk J Obstet Gynecol       Date:  2022-03-28

2.  Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial preparation prior to frozen embryo transfer in women with polycystic ovary syndrome.

Authors:  Yingying Zhang; Ling Wu; Tin Chiu Li; Chi Chiu Wang; Tao Zhang; Jacqueline Pui Wah Chung
Journal:  Reprod Biol Endocrinol       Date:  2022-04-02       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.